InteRNA’s R&D collaboration partner UMC St. Radboud, Department of Experimental Urology, receives € 500,000  grant from Stichting voor de Technische Wetenschappen (STW) for further research and therapeutic development of miRNAs that may prevent metastasis formation and increase sensitivity to chemotherapy by reversing Epithelial-to-Mesenchymal transition (EMT) of cancer cells.